The cloaca is an embryonic cavity that is divided into the urogenital sinus and rectum upon differentiation of the cloacal epithelium triggered by tissue-specific transcription factors including CDX2. Defective differentiation leads to persistent cloaca in humans (PC), a phenotype recapitulated in Cdx2 mutant mice. PC is linked to hypo/hyper-vitaminosis A. Although no gene has ever been identified, there is a strong evidence for a genetic contribution to PC. We applied whole-exome sequencing and copy-number-variants analyses to 21 PC patients and their unaffected parents. The damaging p.Cys132* and p.Arg237His de novo CDX2 variants were identified in two patients. These variants altered the expression of CYP26A1, a direct CDX2 target encoding the major retinoic acid (RA)-degrading enzyme. Other RA genes, including the RA-receptor alpha, were also mutated. Genes governing the development of cloaca-derived structures were recurrently mutated and over-represented in the basement-membrane components set (q-value < 1.65 Â 10
Introduction
Persistent cloaca (PC) is the most extreme congenital anorectal problem and is characterized by the convergence of the rectum, vagina, and urethra into common channel that opens into a single perineal orifice. Intrinsically associated complications include hydrocolpos (vagina filled with fluid), other congenital anomalies such as duplicate Mullerian system (uterine malformation), and/or life-threatening urological abnormalities among others. Its treatment, reconstructive surgery, is a challenge for the pediatric surgeon, whose main concern is to restore urinary and bowel control and, eventually, sexual and reproductive functions of the patient (1, 2) . Many patients require multiple surgical procedures and life-long surveillance is mandatory.
PC is rare (1/20 000 live births), occurs sporadically (no family history) and exclusively in females. The condition is attributed to a failure of the urorectal septum to descent during early fetal development. The causes of this developmental failure are not known, yet there is a strong evidence for a genetic component as PC may be present in multisystem syndromes of genetic origin including Townes-Broks, Currarino, Pallister-Hall and Down syndromes, tetrasomy 12, trisomy 18 and isochromosome 18q (3, 4) . Furthermore, animals with alterations in genes or pathways required for the proper development of the caudal region present phenotypes reminiscent of cloaca. Among those are bone morphogenetic protein (BMP) (5), c-Jun N-terminal kinase (JNK), Shh (6), Wnt (7), Ephrin (8) , Skt (9) and retinoic acid (RA) signaling systems (10) . Also, several epidemiologic studies as well as animal experiments have linked both hyper-and hypovitaminosis A to anorectal malformations (11, 12) .
In spite of the evidence for a genetic cause underlying cloaca, no specific gene or pathway or chromosomal anomaly has been singled out as a probable cause or basis for the disorder. A cyto-genomic microarray analysis study on copy number variants (CNV) in 17 PC females (13) detected a de novo 7.245 Mb deletion in one patient that included a plausible candidate, the hedgehog acyltransferase gene (HHAT) yet, no HHAT mutations were found in independent cloaca patients. No pathogenicity could be attributed to those inherited gains or losses detected. Likewise, the screening of cloaca patients for pathological DNA variations in the coding sequences (CDS) of genes that recapitulate the PC phenotype in mice has not proved fruitful (3, 14) . Yet, a study conducted on human tissue samples of PC patients, controls and Shh knockout mice (recapitulates PC phenotype) showed that PC may be caused by defects in the differentiation of the embryonic cloacal epithelium (15) due to disturbed SHH and BMP signaling, which can be molecularly detected even before septation, -when the embryonic cloaca still exists-. Defective epithelial differentiation gives rise to an indeterminate epithelium in the common channel where the BMP and SHH signaling is reduced/absent and there is alteration of the expression of transcription factors such as the Caudal Type Homeo Box Transcription Factor 2, (CDX2) and SOX2. These factors are key in defining the nature and fate of the embryonic cloaca epithelium (7, 15) .
It is plausible that DNA alterations in genes governing the development of the caudal region lead to PC. Therefore, we have applied whole-exome (WES) sequencing -to which we have applied a customize variant prioritization approach-and a comprehensive CNV analysis to 22 PC females and their unaffected parents under the hypothesis that rare, either de novo or recessively inherited damaging DNA alterations may underlie such a rare, severe, sporadic congenital disorder that is PC. This hypothesis accounts for sporadic presentation of PC, along with its severity and scarcity. The de novo events could explain why such a devastating disorder that even compromises reproductive fitness still occurs.
Results
Downstream analysis was therefore performed on 21 trios (Supplementary Material, Table S1 ). Sequencing and quality control (QC) metrics are detailed in Supplementary Material, Table S2 . In brief, the coverage of the targeted exonic sequences per sample ranged from 31X to 61X (average 40X), and the targeted exome covered by at least 10 sequence reads ranged from 81% to 97% (average 91%). One trio out of the 22 included in the study had to be removed due to contamination.
De novo SNV/indels and CNV variants analysis: damaging de novo SNVs in CDX2 detected in unrelated patients First, we focused our analysis on de novo SNVs and CNVs, including only high quality calls. For SNVs and indels, the minor allele frequency (MAF) was set according to different inheritance modes tested, and only CNVs not present in the Database of Genomic Variants (DGV) nor in our in-house controls were considered. After filtering, a total of 18 high confidence de novo events including 11 single-nucleotide variants (SNVs) (Supplementary Material, Table S4) and 7 CNVs (Supplementary Material, Table  S5 ) were selected. There was an average of 0.52 de novo exonic SNVs per genome -which is in line with reported rates (16)-and, an average of 0.33 putative de novo CNVs intersecting genes per individual.
The 11 de novo SNVs were distributed in 10 genes and were all validated by Sanger sequencing. Four out of the 10 genes had been ascribed to human disorders (Supplementary Material, Table S4 ), yet none of these specific disorders affected any of patients nor was PC part of their phenotypic spectrum. The genes with de novo mutations were inquired according our in-house Inheritance Modes Specific Pathogenicity Prioritization (ISPP) (17) method (Supplementary Material, Table S4 ). Yet, not all those genes could possibly underlie PC and further filtering was performed according to their biologically plausibility, gene function during developmental stages as well as the phenotype displayed by mutant mice (Supplementary Material, Table S4 ). Four genes (SLC9A3, TNS3, TNFRSF1A, CDX2) all with damaging SNVs appear to cause abnormalities of the hindgut in mice yet the most plausible de novo mutated gene was the Caudal Type Homeo Box Transcription Factor 2, CDX2. Firstly, two severe damaging de novo mutations (p.Cys132* and p.Arg237His) were detected in 2 out of 21 patients [the identification of de novo variants in the same gene in unrelated patients with the same sporadic disorder is a strong argument in favor of gene pathogenicity or involvement of the gene in the disease (18) ]. Secondly, CDX2 encodes an intestine-specific transcription factor whose role in defining the nature of the cloaca and urothelial differentiation in both human and mice is indisputable (7, 15) . Moreover, Cdx2-/-mice have severe hindgut abnormalities with failure of colon development and complete terminal blockage (19) .
Among the de novo genic CNVs (Supplementary Material, Table S5 ), noteworthy is a 24 Kb duplication encompassing COL5A2 (see below) detected in patient IA704. Importantly, damaging compound heterozygous in COL5A1 were detected in another patient (VL23).
Defective function of the mutated CDX2 proteins (in vitro and in silico)
As the implication of CDX2 in cloaca septation is well established, we assessed the effect of the de novo variants on the function of the protein.
The two CDX2 de novo mutations (R237H, C132*) are novel in The Genome Aggregation Database (gnomAD), consisting of 123, 136 exome and 15, 496 whole-genome sequences from unrelated individuals with non-congenital diseases, which emphasizes the evolutionary constrain of the gene region (Fig. 1A) .
The CDX2 gene consists of 3 exons and, intuitively, the stop codon p.Cys132* in exon 1 would trigger the non-sense mediated mRNA decay (NMD) surveillance mechanisms whereby mRNAs harboring premature termination codons (PTCs) are degraded. This would result in CDX2 haploinsufficiency which in mice manifests as a severely compromised gut and cloacal-derived organogenesis (20) . Even though the NMD were bypassed, the protein synthesized would be shortened by 181 residues and would lack the homeobox domain and a few residues of the activation region, losing therefore its regulatory role. Most likely, this truncated protein would have a severe dominant-negative effect on the wild-type counterpart.
The Arg237 residue lays in the homeodomain region (residues 189-239; http://www.uniprot.org/uniprot/Q99626), which is a DNA binding domain, between two residues that establish specific contact with DNA (21) . The predictive models from Phyre2 Protein Homology/analogY Recognition Engine V 2.0 and SuSPect indicated that the Arg237 site has higher mutation sensitivity compared with adjacent regions and therefore, its substitution with a histidine (His) is predicted damaging (Fig.  1B) . SWISS-MODEL protein modelling also suggested that the Arg237His substitution might alter the conformation of the secondary loop structure in the DNA binding domain (Fig. 1C) . The impact of Arg237His was tested on CDX2 direct target genes namely WNT3A, T (15, 22) and CYP26A1 (7). CYP26A1 encodes the major embryonic RA-degrading enzyme, which is essential for the development of posterior structures and importantly, RA signaling can be altered by Cdx2 malfunctioning (22, 23) . As shown in Figure 2 , the Arg237His mutation enhances the expression of the CYP26A1 -possibly by enhancing its binding affinity to the DNA or to co-activators or by weakening its binding to co-repressors-.
From the data above, it would appear that on the one hand, C132* may cause CDX2 haploinsufficiency whereby CYP26A1 expression would be compromised, and on the other hand, the expression of the latter would be enhanced by the Arg237His. The apparently opposite effects that the CDX2 variants may have on CYP26A1 are in fact in line with the rigorous control and balance of the RA signaling needed for the proper development of the caudal region where an uneven RA distribution along the anterior-posterior axis is required (24) . The latter is achieved through positive and negative feedback mechanisms where the control of RA degradation by CYP2A1 is essential (7, 22, 25) . Both excess and deficiency of RA (vitamin A) are known to cause developmental defects in mice and humans and can be linked to CYP26A1 activity. While in mice Cyp26a1 inactivation results in an excess of RA and caudal defects similar to CDX and Wnt mutations (23), Cyp26a1 overexpression results in intracellular RA depletion that also leads developmental defects (25, 26) . Thus, it is tempting to speculate that the increase in CYP26A1 due to the CDX2 Arg237His mutation may ultimately lead to an excess of RA degradation and depletion of RA. Conversely, reduction of CYP26A1 due to CDX2 haploinsufficiency (p.Cys132*) might result in toxic levels of RA either excess or defect of Wnt-b-catenin signaling (27, 28) .
Homozygosis and compound heterozygosis
We then tested an autosomal-recessive mode of inheritance and identified genes with homozygous damaging (Supplementary Material, Table S6 ) and/or compound heterozygous (CH) (Supplementary Material, Table S7 ) variants. After filtration and, based on our de novo findings and on the relevance of RA in development, the gene RARA, encoding the RA receptor alpha, was the most relevant gene among those with homozygous and CH damaging SNVs. Indeed, depletion of RA receptors is known to promote teratogenic increases in RA (10) . Also CH damaging SNVs in COL5A1, COL7A1, PLEC and FERMT1 caught our attention. COL5A1 (and also COL5A2) underlies Ehlers-Danlos syndrome (cEDS; Online Mendelian Inheritance in Man (OMIM) 1300), a connective tissue disorder, and COL7A1, PLEC and FERMT1 underlie different types of epidermolysis bullosa (epithelial disorder) known to occasionally co-exist with anorectal malformations of several degrees of severity in some patients. CH damaging SNVs were identified in KMT2D. KMT2D underlies Kabuki syndrome, a congenital condition afflicting many parts of the body that, occasionally, includes anorectal malformations in its wide phenotypic spectrum.
Analysis of the functional overlap among genes and patients genetic profile involves the RA and extracellular matrix components in PC We also considered a di/oligo-genic recessive model where variants in two or more interacting genes co-exist in a patient. Thus, patients were scrutinized for mutated genes encoding interacting partners to any of the genes presently identified (Supplementary Material, Table S8 ) as well as for new mutated gene-pairs encoding interacting proteins that could be relevant to the development of the caudal region. Remarkably, we identified several recurrent gene-pairs with different site variants. Though little can be said about the relevance of these "di-genic" variants, the fact that: i) most pairs encode components of the basal membranes (HSPG2-NID2 -perlecan and nidogen-, LAMB2-LAMC1 -laminins-, and collagens) or signaling molecules that either interact or belong to pathways involved in the development of the caudal region including SHH, BMP and NOTCH, and No difference in expression of CYP26A1 mRNA were observed between the empty vector and the wild type. This indicates that the CYP26A1 expression driven by endogenous CDX2 cannot longer be enhanced by exogenous CDX2 (saturated). However, when cells were transfected with the mutated vector (R237H), the CYP26A1 expression increased significantly. the fact that ii) all of these gene-pairs are present in more than one patient but bearing different rare alleles made it difficult to ignore them. Importantly, two patients had mutations in the interacting pair NOTCH1-RBP3. RBP3 encodes a retinol acid binding protein that although it is known for its role in visual structures development, it is also expressed in the caudal region. Also, the pair form by the insulin receptor substrate gene (IRS1) and janus kinase (JAK2) was detected in two patients. Although, IRS1 is linked to diabetes mellitus which is a known risk factor for caudal regression syndrome, this variant was paternally inherited in one of the patients.
Using the data described above, we generated a genetic profile for each patient (Fig. 3, Supplementary Material, Table S9 ) to help find communalities among them in despite the apparent genetic heterogeneity observed. A relevant feature is the finding of 5 (VL6: CDX2; VL17: RBP3; VL21: CDX2, VL22: RBP3, VL30: RARA) patients out of 21 with damaging variants in genes implicated in RA. Yet, gene-enrichment joint analysis of the genetic profiles indicated that the main pathway shared by these patients was the KEGG pathway: Extracellular matrix (ECM)-receptor interaction pathway as this network has significantly more interactions in the patients than expected (MsigDB ID: M7098, FDR, q-value <7.16Â10 À9 ) and importantly, includes many genes that underlie human disorders caused by deficiencies in ECM components as illustrated by the gene-pairs mentioned above and the damaging variants in collagen and other genes underlying epithelial disorders. Importantly, those genes recurrently mutated were over-enriched in the basement-membrane gene set (MSigDB ID: M5887; FDR, q-value < 4.75Â10 À7 ).
Besides, the hypergeometric test indicated that the genes with rare damaging mutations identified in the PC cohort (n ¼ 129 genes) were statistically over-represented (P-value < 5.1Â10 À5 ) in the pediatric disease genes of CGD (n ¼ 1583)
considering that number of protein coding genes is 19 091 [HUGO Gene Nomenclature Committee (HGNC)].
Genotype-phenotype correlation in PC patients with concomitant anomalies
Among the PC patients analysed, 3 (IA682, IA691 and IA704) had additional congenital anomalies. Therefore, we wondered if the mutations identified in those patients could also account for these additional congenital defects (Supplementary Material, Table S1 ). IA682 carries damaging CH variants in MAN1B1, a gene that could account for the global developmental delay. Yet, looking at the genetic profile of this patient it is hard to tell whether the observed features, indeed including PC, result from the effect of a single gene or from the joint effect of the several damaging alleles detected in her exome. Patient IA704, diagnosed with caudal regression syndrome with PC also had vesicoureteral reflux, haemangioma of the thigh, atrophy of the right calf muscle and right talipes equinovarus and mild developmental delay, had a de novo variant in a gene that hardly could be related to the phenotype (DBNL; Supplementary Material, Table S4 ) and a de novo CNV duplication encompassing COL5A2 (Supplementary Material, Table S5 ). COL5A2 as well as COL5A1 mutations and duplications have been reported in Ehlers-Danlos syndrome (29) . Interestingly, CH mutations in COL5A1 were detected in patient VL23. IA704 also had CH (Supplementary Material, Table S7 ) variants in MYH4 and in the interacting gene pair formed by the insulin receptor substrate gene (IRS1) and janus kinase (JAK2). No human disorder has been ascribed to MYH4 and whether the variants in the pair IRS1-JAK2 can account for the rest of anomalies is hard to tell.
Discussion
To comprehend this rare devastating disorder we conducted a WES and a comprehensive CNV analysis on 21 PC females and their unaffected parents under the hypothesis that rare, either de novo or recessively inherited damaging DNA alterations may underlie a rare, severe, sporadic congenital disorders. This would be the first exome sequencing study in PC patients. From the data presented here, it is obvious that, in spite of the severity and rarity of the disorder, the one gene-one phenotype model notion does not apply to PC and indeed, given the rarity and heterogeneity of the disorder, establishing disease causality for any given gene is extremely difficult. Thus, we have produced the genetic profile of each patient (Supplementary Material, Table S9 ) to find possible common grounds among them and to draw plausible explanations for the phenotype. Indeed, amid the expected characteristic genetic heterogeneity (30, 31) , we show here that 5 out of 21 (23%) patients have mutations genes related to RA metabolism and all patients have at least one damaging allele in genes encoding proteins components of the basement membranes, including laminins, collagens, nidogens and perlecan. In fact, several of these genes are recurrently mutated at different sites in independent patients (Supplementary Material, Table S8 ) as genepairs (e.g.: HSPG2-NID2), CH (e.g.: HSPG2) or CH and CNV forms (e.g.: COL5A1/COL5A2). Taken together, these findings are reminiscent of the postulated mechanisms governing mouse caudal development whereby crosstalk between CDX genes, RA, Wnt, Shh signaling and ECM components is essential (32) .
The most intriguing and consequential finding is the discovery of damaging alleles in genes involved in the RA metabolism. Particularly relevant is CDX2, with two patients with a different de novo functional variant (truncation and missense) each. Importantly, this is the first time that a gene that recapitulates the PC phenotype in mouse models is found mutated in humans. Yet, it is not possible to state that the CDX2 damaging variants or those in RA genes can account for the PC phenotype by themselves, but given the irrefutable evidence of the role played by these genes in the development of cloaca derivatives, let alone the evidence provided by animal models, we are confident to state that at least, damaging alleles in these genes contribute to the cloaca phenotype in humans. Yet, not all patients have mutations in these genes and the contribution of ECM molecules to the phenotype may be more controversial or difficult to establish even though there is also a wealth of evidence for a role of EMC in the development of cloaca derivatives. In fact, the genetic profile of these patients advocates for a disease model where both genetic heterogeneity and oligogenecity are needed to explain the phenotype. This is consistent with the fact that damaging genetic variants in one or several genes orchestrating the development of the cloaca derivatives (the cloaca is a temporal structure that is subsequently divided into the urogenital sinus and rectum) could underlie PC. We have to bear it in mind that the effect (or effects) of variants could be potentiated by each individual's genetic background therefore making virtually impossible to establish causality. Damaging variants in genes known to cause disease have indeed been detected, yet again, as illustrated above, the phenotype to which the mutated gene has been ascribed to, is not manifest in the patient. This lack of genotype-phenotype correlation is indeed not unique to the condition studied here and it seems to be the norm in non-monogenic disorders.
We are aware that the data presented here are small and that establishing causality may require the screening of a large number of patients to statistically associate genes with the disease and an equally prohibitive battery of functional tests to elucidate the disease mechanism for each gene. Indeed, genetic heterogeneity in rare disorders is having an impact on the scientific community when it comes to link or associate genes with rare diseases as prohibitive large sample sizes are required and because of the nature of the disorder, such sizes are simply unachievable. Therefore, we believe the fact that different de novo functionally proven mutations in a really plausible gene have been identified in 2 out of 21 is indeed suggestive of causality. We believe that our data points to a gene and a pathway that will be really valuable in future investigations on patients with the same phenotype (33, 34) .
Materials and Methods

Patients
Trios. A total of 22 ethnic Chinese trios (affected female child and unaffected parents) without family history of PC were submitted to WES and CNV analysis. Clinical characteristics of the patients are detailed in Supplementary Material, Table S1 . Blood samples were drawn from all participants after obtaining informed consent (parental consent in new-borns and children below age 7) and experiments were carried out in "accordance" with the approved guidelines. This study was approved by the Institutional Review Board of The University of Hong Kong/ Hospital Authority Hong Kong West Cluster (HKU/HA HKW IRB) with UW 12-383.
Data generation
Whole-exome sequencing. Library preparation and exome enrichment was performed using TruSeq (Illumina, San Diego, CA, USA) and xGen Exome Research Panel v1.0 (Integrated DNA Technologies, Iowa, USA). Sequencing was done in an Illumina HiSeq2000 platform with 100 base pair-end read length. Burrows-Wheeler aligner (BWA) was used to align sequence reads to the human reference genome (build 19) (35) . Sequence and alignment quality were evaluated using the FastQC toolbox and Picard CollectHsMetrics module respectively (QC; Supplementary Material, Table S2 ) followed by Genome Analysis Toolkit (GATK) (36) best practice.
Genome-wide SNP array. To analyse CNVs, DNA was hybridized to Infinium HTS assay (Illumina, San Diego, CA, USA) according to standard protocols.
Data analysis
SNV/indel calling and prioritization. SNVs and small indels were called by GATK Haplotypecaller. Only variants meeting the following criteria were considered: i) minimal genotype Phred score of 20; ii) minimal coverage of 8X; iii) if alternative alleles were detected in less than 5% of the reads then they were considered as reference alleles; iv) if alternative alleles were detected in more than 25% of the reads then they were considered as heterozygous alleles; v) the minimal average quality Phred score of each variant across all samples had to be 30; vi) minimal mapping quality Phred score for each variant, 20 per read; vii) Phred-scaled P-value for overall strand bias, by using Fisher's exact test, 60 per each variant; viii) missing genotyping rate, <20%; ix) for SNVs, variants with Variant Quality Score Recalibration (VQSR) >99.50 were excluded, and for small indels, we excluded those with VQSR > 95.
Sample contamination, identity by descent (IBD), gender and population stratification (by principle component analysis) were checked by Plink (37) .
We assumed that the MAF of the putative disease-related variants should approximately match the prevalence of PC in the general population. As a result, MAF information from the exome aggregation consortium (ExAC; exac.broadinstitute.org/) and from the latest 1000 Human Genome was used for all downstream filtering and annotation by KGGSeq version 1.0 (Supplementary material). Only rare non-synonymous variants were prioritized according to the hypothesis being tested. To inquire about the potential pathogenicity all SNV/Indels and CNVs together with their corresponding genes were examined in various public databases including RefGene, ClinVar, OMIM, mouse genome informatics (MGI), international mouse phenotyping consortium (IMPC) and Deciphering Developmental Disorders (DDD) project. The deleteriousness of each nonsynonymous SNV was estimated by SIFT, Polyphen2(HDIV) and CADD. To further assess the impact of each mutated gene, ISPP (17) was used to predict the gene level pathogenicity giving corresponding inheritance mode of variants. Furthermore, for de novo, homozygous and CH mutations, those genes with ISPP-PAE scores equal to zero were excluded. ISPP-PAE score indicates if the genes share pathogenic features with the pediatric disease genes as defined in the clinical genomic database CGD (https://research.nhgri.nih.gov/CGD/).
As we hypothesized that monogenic and di-genic recessive inheritance models could fit the presentation of PC, we considered the following i) de novo mutation; ii) homozygous variations; iii) CH, and iv) variants in two different but interacting genes (di-genic mutations; PPIs). For de novo mutations, only novel (MAF ¼ 0 in ExAC), non-inherited non-synonymous alleles were considered. As PC is congenital and sporadic -could be due to de novo mutations-we listed the gene level pathogenicity score ISPP_AD, ISPP_PAE and Gene Constrain. Under the assumption of a recessive model where homozygous, CH and PPIs only variants inherited from different parents were considered, that is, we required both maternal and paternal rare alleles. Since rare variants are more likely to cause disease, allele frequency for inherited variants was restricted to < ¼1% MAF giving an incidence for any such combination in an individual of < ¼0.01%. Under this assumption, gene level pathogenicity scores ISPP_AR and ISPP_PAE were considered and those genes with ISPP scores ¼ 0 for either model were excluded. Variantlevel pathogenicity predictions by SIFT and Polyphen2 were used for variants in CH. Only CH variants (2 variants ! 4 prediction results) predicted possibly damaging or above at least three times were reported, unless the variant is a stop-gain/loss and/ or the corresponding gene is associated with a caudal malformation. For di-genic mutations we resorted to the Disease Association Protein-Protein Link Evaluator (DAPPLE) to determine if the genes with rare non-synonymous SNVs present in a given patient encoded interacting proteins. The "interactive" gene pair should not be present in the parents. Only those recurrent PPI events in patients were considered. A pipeline integrating BWA, Picard, GATK, Plink, KGGSeq and ISPP was used to generate final set of qualified variants (Supplementary Materials, Tables S1-S9).
CNV detection and analysis. The GenomeStudio program (Illumina, San Diego, CA, USA) was used to normalize and analyse the SNP array data as mentioned above. PennCNV and Plink were used to call and to prioritize CNVs. Loss (deletion) and gain (duplication) were defined as the change of a minimum of a 10kb region, with a maximum standard deviation of Log R radio ¼ 0.35 and Wave Factor threshold ¼ 0.1. Only PC patient unique CNVs were included. Bedtools and Plink were used to cross-check PC's CNV calls against the DGV; http://dgv. tcag.ca/dgv/app/home) as well as our in-house local reference data that consist of 140 healthy controls plus 48 non-PC patients. The identified CNVs were annotated if they overlapped with genes. The overlapping genes were cross-checked with OMIM.
Gene-enrichment & hypergeometric test. To identify whether a set of mutated genes in this PC cohort is statistically overrepresented in a gene set or pathway, we performed hypergeometric and gene-enrichment tests against the pediatric disease causal genes reported in CGD as well as in C2, or curated gene sets (MSigDB; http://software.broadinstitute.org/gsea/msigdb/ collections.jsp#C2).
Protein structure prediction. The FASTA protein sequence NP_001256 as well as the mutated counterpart were submitted to SWISS-MODEL (38) and Protein Homology/odelin Recognition Engine V 2.0 (PHYRE2) (39) for protein 3D odeling and analysis of the effect of amino acid variants on the protein structure (http://www.sbg.bio.ic.ac.uk/phyre2).
Expression of the CDX2 protein
Plasmids. The human CDX2 expression vector (wild-type CDX2 in pHR/CMV) was from Addgene (Cambridge, MA). Mutations were introduced using QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA, USA). The human wild-type (WT) and mutants (C132* and R237H) Cdx2 cDNA were then subcloned into pEGFP-C2 expression vector.
Cell culture and transfection. The human colon cancer lines HCT116 and SW480 were provided by Dr. Lui NG (Department of Surgery, The University of Hong Kong). Both cell lines were cultured in Dulbecco's Modified Eagle Medium (Invitrogen) supplemented with 10% FBS and 100 U/ml penicillin-streptomycin. Approximately 4Â10 6 cells were seeded in 6-well cell culture plates one day before transfection. Cells were transfected with 3 mg of plasmids using Lipofectamine TM 3000 Transfection Reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's recommendation. Twenty four hours after transfection, cells were harvested and total RNA was extracted using RNeasy mini kit (QIAGEN Inc.).
Quantitative real-time PCR. 1 mg total RNA was used to synthesize complementary DNA (cDNA) using PrimeScript TM RT reagent kit with gDNA Eraser (Takara Bio Inc.). Quantitative real-time PCR was performed using iTaq TM Universal SYBR V R Green Supermix (BIO-RAD Laboratories, Inc., Hercules, CA) in a 7900HT Fast Real-Time PCR System (Applied Biosystems). Primers for real-time PCR of the genes of interest are listed in Supplementary Material, Table S3 . Expression of each gene was normalized to the expression of human 18S. Real-time PCR was carried out in triplicates for three independent experiments.
Supplementary Material
Supplementary Material is available at HMG online.
